These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25190487)

  • 1. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.
    Chen P; Zeng M; Zhao Y; Fang X
    Oncol Rep; 2014 Nov; 32(5):2070-6. PubMed ID: 25190487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
    Cai S; Chen R; Li X; Cai Y; Ye Z; Li S; Li J; Huang H; Peng S; Wang J; Tao Y; Huang H; Wen X; Mo J; Deng Z; Wang J; Zhang Y; Gao X; Wen X
    Oncotarget; 2015 Feb; 6(6):3904-17. PubMed ID: 25714010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
    Zhou Y; Su J; Shi L; Liao Q; Su Q
    Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway.
    Jia Y; Li Y; Du N; Zhao W; Liu Y
    Aging (Albany NY); 2024 Jul; 16(13):11090-11102. PubMed ID: 38975937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
    Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
    Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
    Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
    Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells.
    Park GB; Kim D
    Anticancer Res; 2017 Apr; 37(4):1805-1818. PubMed ID: 28373445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer.
    You T; Gao W; Wei J; Jin X; Zhao Z; Wang C; Li Y
    Biomed Pharmacother; 2015 Feb; 69():96-101. PubMed ID: 25661344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
    Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
    Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
    Xu J; Ma X; Yang H; Zhang J; Cai G; Yao N
    Chem Pharm Bull (Tokyo); 2021; 69(4):325-332. PubMed ID: 33790078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
    Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
    Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.
    Sheng H; Guo YH; Cao DS; Li XJ; Zhao Y; Ding H; Zhang YL; Chen ZH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2625-2631. PubMed ID: 32196612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
    Vlecken DH; Bagowski CP
    Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
    Xia H; Sun S; Wang B; Wang T; Liang C; Li G; Huang C; Qi D; Chu X
    Int J Mol Sci; 2014 Jul; 15(7):11973-83. PubMed ID: 25003638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
    Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1.
    Qiao Y; Jin T; Guan S; Cheng S; Wen S; Zeng H; Zhao M; Yang L; Wan X; Qiu Y; Li Q; Liu M; Hou Y
    Oncogene; 2021 Jun; 40(24):4198-4213. PubMed ID: 34079084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
    Zhao J; Li D; Fang L
    Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.